Survey: Few women told by doctor that breastfeeding can reduce cancer risk

October 25, 2018

A new survey shows that although nearly 60 percent of breastfeeding mothers knew about the link between breastfeeding and breast cancer risk reduction, just 16 percent say they learned this from a medical professional.

This is concerning, says study principal investigator Bhuvana Ramaswamy, MD, because women should be informed that breastfeeding can reduce breast cancer risk and improve mother's health. Epidemiological studies show strong correlation between prolonged breastfeeding and reduced risk of developing triple negative breast cancer, an aggressive form of breast cancer. This knowledge is especially relevant for African American women considering whether to breastfeed, who are two times more likely to develop triple negative breast cancer when compared with women of other ethnicities.

"We have a duty as a medical community to ensure our patients have reliable knowledge," said Ramaswamy, breast medical oncology division director at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). "When it comes from a professional, medical information is much more likely to affect people's choices. When it comes to breast cancer specifically, prevention is the best outcome."

For this study, OSUCCC - James researchers conducted a survey of 724 women who had at least one live birth. Survey respondents were recruited through the Ohio State University Wexner Medical Center primary care practices and a national clinical research registry.

While a majority of respondents - 92 percent - reported that they had chosen to breastfeed, only 56 percent of all respondents noted that they were aware of the link between prolonged breastfeeding and breast cancer risk reduction prior to making the decision. Among those that did not breastfeed, 59 percent say that knowledge of this risk reduction would have impacted their decision to breastfeed.

The data was published in the medical journal Breastfeeding Medicine.

Ongoing Research:

This survey was part of larger research effort at the OSUCCC - James exploring the specific mechanisms of how breastfeeding reduces a woman's risk for breast cancer.

Previous studies suggest that giving birth and breastfeeding lowers a woman's overall risk of developing breast cancer, with the most recent data pointing to breastfeeding being protective specifically against triple-negative breast cancers. African-American/black women have a disproportionately high rate of developing aggressive triple-negative breast cancer while also having higher birth rates and lower rates of breastfeeding. Research has also shown that women native to Africa have higher rates of breastfeeding and lower rates of breast cancer. The reasons how breastfeeding affect breast cancer risk remain unclear but research suggests that it may be related to pro-inflammatory processes coordinated by STAT3 activation.

Ramaswamy is leading a basic science study that will test the hypothesis that an overarching biologic mechanism of altered STAT3 activation triggering a proliferative/inflammatory environment in the breast tissue that did not undergo gradual involution following pregnancy and prolonged breastfeeding results in a higher risk for breast cancer. Knowledge gained in this study is expected to enhance knowledge of the biological mechanisms underlying the connection between breastfeeding and breast cancer risk, particularly difficult-to-treat triple-negative breast cancers. This will also help identify prevention strategies for mothers who are unable to breastfeed. The ongoing study is funded by Pelotonia, a grassroots cycling event that has raised more than $156 million for cancer research conducted at the OSUCCC - James.
-end-


The Ohio State University Comprehensive Cancer Center

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.